共 102 条
[1]
Ferlay J(2013)Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur J Cancer 49 1374-1403
[2]
Steliarova-Foucher E(2012)The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary J Urol 188 2219-2224
[3]
Lortet-Tieulent J(2016)EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer Eur Urol 71 630-642
[4]
Rosso S(2017)A framework for treatment decision making at prostate cancer recurrence Med Decis Mak 1 272989X17711913-943
[5]
Coebergh JWW(2011)Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by (11C)choline positron emission tomography/computed tomography Eur Urol 60 935-309
[6]
Comber H(2015)Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years Eur Urol 67 299-849
[7]
Forman D(2015)Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy Eur Urol 67 839-2041
[8]
Bray F(2007)Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2035-486
[9]
Mullins JK(2014)Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy Eur Urol 66 479-1016
[10]
Feng Z(2009)Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study Int J Radiat Oncol Biol Phys 73 1009-611